Access the full text.
Sign up today, get DeepDyve free for 14 days.
Katharina Ruebel, Long Jin, X. Qian, B. Scheithauer, K. Kovacs, N. Nakamura, Heyu Zhang, A. Raz, R. Lloyd (2005)
Effects of DNA methylation on galectin-3 expression in pituitary tumors.Cancer research, 65 4
R. Patterson, Wei-zhong Wang, John Wang (2004)
Understanding the biochemical activities of galectin-1 and galectin-3 in the nucleusGlycoconjugate Journal, 19
T. Shimamura, M. Sakamoto, Y. Ino, K. Shimada, T. Kosuge, Yasuto Sato, Katsuaki Tanaka, H. Sekihara, S. Hirohashi (2002)
Clinicopathological significance of galectin-3 expression in ductal adenocarcinoma of the pancreas.Clinical cancer research : an official journal of the American Association for Cancer Research, 8 8
G. Benvenuto, M. Carpentieri, P. Salvatore, L. Cindolo, C. Bruni, L. Chiariotti (1996)
Cell-specific transcriptional regulation and reactivation of galectin-1 gene expression are controlled by DNA methylation of the promoter regionMolecular and Cellular Biology, 16
H. Ahmed, P. Banerjee, G. Vasta (2007)
Differential expression of galectins in normal, benign and malignant prostate epithelial cells: silencing of galectin-3 expression in prostate cancer by its promoter methylation.Biochemical and biophysical research communications, 358 1
(1995)
Expression and function of galectin-3, a b galactoside-binging Lectin, in human monocytes and macrophages
R. Bresalier, N. Mazurek, L. Sternberg, J. Byrd, C. Yunker, Pratima Nangia-Makker§, A. Raz (1998)
Metastasis of human colon cancer is altered by modifying expression of the beta-galactoside-binding protein galectin 3.Gastroenterology, 115 2
H. Lahm, S. André, A. Hoeflich, H. Kaltner, H. Siebert, B. Sordat, C. Lieth, E. Wolf, H. Gabius (2003)
Tumor galectinology: Insights into the complex network of a family of endogenous lectinsGlycoconjugate Journal, 20
A. Danguy, I. Camby, R. Kiss (2002)
Galectins and cancer.Biochimica et biophysica acta, 1572 2-3
M. Kane, M. Loda, Gretchen Gaida, J. Lipman, R. Mishra, H. Goldman, J. Jessup, R. Kolodner (1997)
Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines.Cancer research, 57 5
G. Choufani, N. Nagy, S. Saussez, H. Marchant, P. Bisschop, M. Burchert, A. Danguy, S. Louryan, I. Salmon, H. Gabius, R. Kiss, S. Hassid (1999)
The levels of expression of galectin‐1, galectin‐3, and the Thomsen–Friedenreich antigen and their binding sites decrease as clinical aggressiveness increases in head and neck cancersCancer, 86
D. Hsu, C. Dowling, K.‐C. Jeng, Jung‐Ta Chen, Riyao Yang, Fu-Tong Liu (1999)
Galectin‐3 expression is induced in cirrhotic liver and hepatocellular carcinomaInternational Journal of Cancer, 81
T. Irimura, Y. Matsushita, R. Sutton, D. Carralero, D. Ohannesian, K. Cleary, D. Ota, G. Nicolson, R. Lotan (1991)
Increased content of an endogenous lactose-binding lectin in human colorectal carcinoma progressed to metastatic stages.Cancer research, 51 1
Peter Jones, S. Baylin (2002)
The fundamental role of epigenetic events in cancerNature Reviews Genetics, 3
A. Raz (2008)
On the Role of Galectin-3 in Cancer Metastasis : From the Bench to the Clinic and BackNihon Kikan Shokudoka Gakkai Kaiho, 59
R. Pacis, M. Pilat, K. Pienta, K. Wojno, A. Raz, V. Hogan, C. Cooper (2000)
Decreased galectin‐3 expression in prostate cancerThe Prostate, 44
S. Shin, T. Nagasaka, B. Jung, N. Matsubara, W. Kim, J. Carethers, C. Boland, A. Goel (2007)
Epigenetic and genetic alterations in Netrin-1 receptors UNC5C and DCC in human colon cancer.Gastroenterology, 133 6
P. Rennie, C. Nelson (1998)
Epigenetic Mechanisms for Progression of Prostate CancerCancer and Metastasis Reviews, 17
S. Barondes, D. Cooper, M. Gitt, H. Leffler (1994)
Galectins. Structure and function of a large family of animal lectins.The Journal of biological chemistry, 269 33
F. Brûle, S. Califice, V. Castronovo (2004)
Expression of galectins in cancer: A critical reviewGlycoconjugate Journal, 19
M. Turker, T. Bestor (1997)
Formation of methylation patterns in the mammalian genome.Mutation research, 386 2
M. Guévremont, J. Martel-Pelletier, C. Boileau, F.‐T. Liu, Michel Richard, J. Fernandes, J. Pelletier, P. Reboul (2004)
Galectin-3 surface expression on human adult chondrocytes: a potential substrate for collagenase-3Annals of the Rheumatic Diseases, 63
Susumu Nakahara, N. Oka, Avraham Raz (2005)
On the role of galectin-3 in cancer apoptosisApoptosis, 10
M. Veigl, L. Kasturi, J. Olechnowicz, Mahamat Ah, J. Lutterbaugh, S. Periyasamy, Guo-Min Li, James Drummond, P. Modrich, W. Sedwick, S. Markowitz (1998)
Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers.Proceedings of the National Academy of Sciences of the United States of America, 95 15
R. Lotan, Hisao Ito, W. Yasui, H. Yokozaki, D. Lotan, E. Tahara (1994)
Expression of a 31‐kDa lactoside‐binding lectin in normal human gastric Mucosa and in primary and metastatic gastric carcinomasInternational Journal of Cancer, 56
H. Gong, Y. Honjo, P. Nangia-Makker, V. Hogan, Nachman Mazurak, R. Bresalier, A. Raz (1999)
The NH2 terminus of galectin-3 governs cellular compartmentalization and functions in cancer cells.Cancer research, 59 24
Gastão Schwarz, Myriam Remmelink, C. Decaestecker, Isabelle Gielen, Vinícius Budel, M. Burchert, F. Darro, A. Danguy, Hans-J. Gabius, Isabelle Salmon, Robert Kiss (1999)
Galectin fingerprinting in tumor diagnosis. Differential expression of galectin-3 and galectin-3 binding sites, but not galectin-1, in benign vs malignant uterine smooth muscle tumors.American journal of clinical pathology, 111 5
Fu-Tong Liu, G. Rabinovich (2005)
Galectins as modulators of tumour progressionNature Reviews Cancer, 5
Khean-Lee Goh, K. Quek, G.T.S. Yeo, Ida Hilmi, Ck Lee, N. Hasnida, M. Aznan, K. Kwan, K. Ong (2005)
Colorectal cancer in Asians: a demographic and anatomic survey in Malaysian patients undergoing colonoscopyAlimentary Pharmacology & Therapeutics, 22
H. Schoeppner, A. Raz, Samuel Ho, R. Bresalier (1995)
Expression of an endogenous galactose‐binding lectin correlates with neoplastic progression in the colonCancer, 75
(2002)
Galectinomics: a lesson in complexity
J. Jost, A. Bruhat (1997)
The formation of DNA methylation patterns and the silencing of genes.Progress in nucleic acid research and molecular biology, 57
A. Arfaoui-Toumi, L. Mahmoud, M. Hmida, M. Khalfallah, S. Regaya-Mzabi, S. Bouraoui (2010)
Implication of the Galectin-3 in colorectal cancer development (about 325 Tunisian patients).Bulletin du cancer, 97 2
K. Hibi, H. Mizukami, Atsushi Shirahata, Tetsuhiro Goto, Makiko Sakata, Y. Sanada (2009)
Aberrant Methylation of the Netrin-1 Receptor Genes UNC5C and DCC Detected in Advanced Colorectal CancerWorld Journal of Surgery, 33
X. Sanjuan, P. Fernández, A. Castells, V. Castronovo, F. Brûle, Fu-Tong Liu, A. Cardesa, E. Campo (1997)
Differential expression of galectin 3 and galectin 1 in colorectal cancer progression.Gastroenterology, 113 6
M. Kim, Juna Lee, D. Sidransky (2010)
DNA methylation markers in colorectal cancerCancer and Metastasis Reviews, 29
M. Lotz, C. Andrews, C. Korzelius, Edward Lee, G. Steele, A. Clarke, A. Mercurio (1993)
Decreased expression of Mac-2 (carbohydrate binding protein 35) and loss of its nuclear localization are associated with the neoplastic progression of colon carcinoma.Proceedings of the National Academy of Sciences of the United States of America, 90
S. Moisan, M. Demers, J. Mercier, T. Magnaldo, E. Potworowski, Y. St-Pierre (2003)
Upregulation of galectin-7 in murine lymphoma cells is associated with progression toward an aggressive phenotypeLeukemia, 17
Sablin Mp, A. Italiano, Span Jp (2009)
[Colorectal cancers: prognostic and predictive factors of response to treatment].Bulletin du cancer, 96 4
X. Xu, A. El-Naggar, R. Lotan (1995)
Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications.The American journal of pathology, 147 3
J. Dumić, S. Dabelić, M. Flögel (2006)
Galectin-3: an open-ended story.Biochimica et biophysica acta, 1760 4
Y. Takenaka, T. Fukumori, A. Raz (2004)
Galectin-3 and metastasisGlycoconjugate Journal, 19
Gillian Smith, F. Carey, Julie Beattie, M. Wilkie, T. Lightfoot, J. Coxhead, R. Garner, R. Steele, C. Wolf (2002)
Mutations in APC, Kirsten-ras, and p53—alternative genetic pathways to colorectal cancerProceedings of the National Academy of Sciences of the United States of America, 99
J. Raimond, D. Zimonjic, C. Mignon, M. Mattei, N. Popescu, M. Monsigny, A. Legrand (1997)
Mapping of the galectin-3 gene (LGALS3) to human Chromosome 14 at region 14q21-22Mammalian Genome, 8
K. Kinzler, B. Vogelstein (1996)
Lessons from Hereditary Colorectal CancerCell, 87
M. Kadrofske, K. Openo, John Wang (1998)
The human LGALS3 (galectin-3) gene: determination of the gene structure and functional characterization of the promoter.Archives of biochemistry and biophysics, 349 1
(2002)
Intracellular function of galectins
A. Hittelet, H. Legendre, N. Nagy, Y. Bronckart, J. Pector, I. Salmon, P. Yeaton, H. Gabius, R. Kiss, I. Camby (2003)
Upregulation of galectins‐1 and ‐3 in human colon cancer and their role in regulating cell migrationInternational Journal of Cancer, 103
Downloaded from http://journals.lww.com/appliedimmunohist by BhDMf5ePHKbH4TTImqenVA5KvPVPZ0P5BEgU+IUTEfzO/GUWifn2IfwcEVVH9SSn on 06/10/2020 RESEARCH ARTICLE Loss of Galectin-3 Expression in Mucinous Colorectal Carcinomas is Associated With 5 CpG Island Methylation in Tunisian Patients Lilia Kria Ben Mahmoud, MSc,* Amira Arfaoui, MSc,* Mariem Khiari, MSc,* Ines Chaar, MSc,* Olfa El Amine, MD,w Abdel Majid Ben Hmida, MD,z Lasaad Gharbi, MD,y Sabeh Regaya Mzabi, MD,w and Saadia Bouraoui, MD*w NH2-terminal domain contains only 12 amino-acid Abstract: The b-galactoside-binding protein galectin-3 (gal-3) residues that control its cellular targeting, and the has pleitropic biological functions and has been implicated in COOH-terminal domain contains the carbohydrate- cell growth, differentiation, adhesion, RNA processing, apop- recognition domains consisting of 140 amino-acid resi- 7–9 tosis, and malignant transformation. To investigate the pattern dues, which define the molecule as a galectin. It is an of inactivation of the gal-3 gene (LGALS3) in colorectal cancers intracellular and extracellular lectin that interacts with (CRC), we studied a series of Tunisian patients with CRC to intracellular glycoproteins, cell surface molecules, and 10–12 identify abnormal methylation in LGALS3 promoter using a extracellular matrix proteins. Gal-3 is involved in methylation-specific PCR. We also examined the gal-3 gene diverse biological processes including cell growth, differ- expression by reverse transcription-PCR and
Applied Immunohistochemistry & Molecular Morphology – Wolters Kluwer Health
Published: May 1, 2011
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.